
Ferronova – Nanoparticle Trial Begins in Patients With Gastric and Oesophageal Cancers
ADELAIDE, Australia–(BUSINESS WIRE)–Australian biotech company Ferronova has announced the initiation of a clinical trial of the company’s FerroTrace® nanoparticle technology in patients with gastric and […]














